Cite

HARVARD Citation

    Rafee, S. et al. (2015). Neoadjuvant Crizotinib in Advanced Inflammatory Myofibroblastic Tumour with ALK Gene Rearrangement. Tumori. 101 (2), pp. e35-e39. [Online]. 
  
Back to record